Rating History for Esperion Therapeutics (ESPR) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for ESPR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/16/2025 Paul Choi Maintain Neutral
(N/A)		 3.00
(4.00)		  
 		   Details